Dima Biotechnology Closed on Ten Million Yuan Angel Round Financing

According to Yiou, Dima Biotechnology has received ten million yuan Angel round financing, followed by Guoqian Venture Capital, Huatai Zijin Investment and ETP Fund. 

This round of financing will mainly be used for the construction of the RECmAb recombinant monoclonal antibody technology platform and the research and development of tumor immune target projects.

Founded in August 2019, Dima Biotechnology is a sino-foreign joint venture company, headquartered in Suzhou, Jiangsu province with its research and development base in Wuhan, Hubei province. Dima Biotechnology provides tumor immune products and services of recombinant monoclonal antibody research and development. Its RECmAb digital monoclonal antibody technology can produce a variety of genera, high-quality monoclonal antibodies.

Dima Biotechnology provides antibody customization outsourcing services to innovative pharmaceutical companies. Currently, CMO/CDMO companies are mainly concentrated in Europe, the United States, and Asia. Chinese and Indian CMO/CDMO companies have been particularly prominent in terms of growth in recent years, as the global CMO/CDMO market is gradually shifting from mature markets in the west to emerging markets such as Asia.

"RECmAb technology platform has advantages in diagnosis and treatment. Hundreds of clones can be obtained in a single immunization, and the therapeutic and diagnostic antibodies can be screened synchronously," ,said Cao Qun, the general manager of Huatai Zijin Investment. 

Guoqian Venture Capital is a professional and market-oriented venture capital institution focusing on equity investment in early-stage projects. It mainly invests in medical devices, vitro diagnostic reagents, and biotechnology. Guoqian Venture Capital helps to commercialize scientific and technological achievements, introduce technical projects, evaluate and push the implementation of innovative projects.

Founded in Nanjing with registered capital of 6 billion yuan, Huatai Zijin Investment provides equity investment and debt investment and invests in other investment funds related to equity investment and debt investment and related investment advisory, investment management, and other financial advisory services.